The Non-Malignant Channel is supported with funding from Agios (Gold).
The Sickle Cell Disease Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BSH 2022 | An insight into the role of the Sickle Cell Society
In this video, John James, OBE, Sickle Cell Society, London, UK, discusses sickle cell disease (SCD) and its impact on the quality of life of patients. Mr James first highlights the challenges of living with SCD, and then discusses the importance of the Sickle Cell Society in campaigning for more treatment options and aiming to improve the quality of care provided to those with SCD, through campaigning and advocating for patients. This interview took place at the 62nd Annual Scientific Meeting of the British Society for Haematology (BSH) 2022, in Manchester, UK.
